CN112315976B - Injectable antibacterial composite hydrogel crosslinked by silver-loaded attapulgite, and preparation method and application thereof - Google Patents
Injectable antibacterial composite hydrogel crosslinked by silver-loaded attapulgite, and preparation method and application thereof Download PDFInfo
- Publication number
- CN112315976B CN112315976B CN202011280301.6A CN202011280301A CN112315976B CN 112315976 B CN112315976 B CN 112315976B CN 202011280301 A CN202011280301 A CN 202011280301A CN 112315976 B CN112315976 B CN 112315976B
- Authority
- CN
- China
- Prior art keywords
- silver
- attapulgite
- composite hydrogel
- loaded
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
An injectable antibacterial composite hydrogel crosslinked by silver-loaded attapulgite, a preparation method and application thereof, which belong to the field of hydrogels and can solve the problems of aggregation and agglomeration of silver nanoparticles in a base material, sudden release, complex preparation process, long period, poor antibacterial timeliness and difficult large-scale application existing in the method of organically combining nano silver and hydrogel, and the preparation method comprises the following steps: mixing a water-soluble monomer and an initiator to initiate polymerization to obtain a pre-polymerization solution; ultrasonically dispersing attapulgite in a siloxane precursor-removed aqueous solution, adding an acid catalyst, filtering, and washing to remove redundant siloxane precursors; ultrasonically dispersing the filtered precipitate in deionized water solution containing a silver source, filtering after saturation adsorption, and washing to obtain the attapulgite material loaded with silver ions; adding the hydrogel into a prepolymerization solution, uniformly dispersing by ultrasonic, and illuminating to obtain the injectable antibacterial composite hydrogel. The injectable antibacterial composite hydrogel has the properties of spreadability, injectability and the like.
Description
Technical Field
The invention belongs to the technical field of hydrogel, and particularly relates to an injectable antibacterial composite hydrogel crosslinked by silver-loaded attapulgite, and a preparation method and application thereof.
Background
Silver nanoparticles (AgNPs) have a high specific surface area, have a very high broad-spectrum killing effect on yeast, aerobic bacteria, fungi, and viruses, and have no report that any bacteria have resistance to them so far, compared to other common antibacterial agents, and thus, silver nanoparticles have been attracting much attention as an effective antibacterial agent. The traditional synthesis method of the silver nanoparticles is a chemical reduction method, and a large amount of toxic chemical reagents such as reducing agents, stabilizing agents and the like are usually required to be added, and the chemical reagents have high cytotoxicity and relatively poor biocompatibility. In addition, the silver nanoparticles are easy to agglomerate and disperse unevenly when the concentration of the silver nanoparticles is high, so that the antibacterial performance of the nano silver is seriously influenced.
A hydrogel is a water-swollen, three-dimensional polymer network. The water-soluble polymer forms a network structure in a physical or chemical crosslinking mode and carries a large amount of moisture, so that the hydrogel is obtained. The hydrogel has similarity with animal soft tissue, has extremely high water content, controllable porous structure and mechanical strength, allows gas exchange, and has certain barrier effect on microorganisms, so that the wound is promoted to heal quickly, and the wound can be easily removed without trauma. However, the traditional hydrogel is brittle and easy to be damaged and lose efficacy by machinery, and on the other hand, the antibacterial property is poor, and the moist environment often causes bacteria at the wound to be rapidly propagated, so that the wound is inflamed and other symptoms are caused; the nano-composite hydrogel formed by organically combining the nano-silver with excellent antibacterial performance and the hydrogel keeps the hydrophilicity and softness of the hydrogel material, and simultaneously endows the hydrogel with excellent antibacterial performance, thereby providing a new idea for developing hydrogel wet dressings. At present, the most common preparation method is that the prepared hydrogel is soaked in a silver ion-containing aqueous solution, and after adsorption saturation, chemical reagents such as a reducing agent, a stabilizing agent and the like are added to reduce silver ions into nano silver; the nano-silver composite hydrogel material prepared in the way usually has the problems of aggregation and agglomeration of AgNPs in a matrix material, burst release and the like, and in addition, harmful chemical agents in a hydrogel system are removed; therefore, the preparation process is complex, the period is long, the antibacterial timeliness is poor, and the large-scale application is difficult.
Disclosure of Invention
The invention provides an injectable antibacterial composite hydrogel crosslinked by silver-loaded attapulgite, a preparation method and application thereof, aiming at the problems of aggregation, agglomeration and 'burst release' of silver nanoparticles in a matrix material, complex preparation process, long period, poor antibacterial timeliness and difficult large-scale application of a method for organically combining nano silver and hydrogel.
The invention adopts the following technical scheme:
an injectable antibacterial composite hydrogel crosslinked by silver-loaded attapulgite comprises 5-20wt% of base material and 80-95wt% of deionized water, wherein the base material comprises 1-10wt% of attapulgite material loaded with nano silver and 90-99wt% of hydrophilic polymer.
A preparation method of injectable antibacterial composite hydrogel crosslinked by silver-loaded attapulgite comprises the following steps:
firstly, mixing a water-soluble monomer and an initiator, and initiating polymerization under the stirring condition to obtain a pre-polymerization solution;
secondly, ultrasonically dispersing the attapulgite in a siloxane-containing precursor aqueous solution, adding an acid catalyst under the stirring condition, after the reaction is finished, filtering and washing to remove redundant siloxane precursors to obtain modified attapulgite, ultrasonically dispersing the filtered modified attapulgite in a deionized water solution containing a silver source, adsorbing and saturating, filtering, and washing to obtain the attapulgite material loaded with silver ions;
and thirdly, adding the attapulgite loaded with silver ions into the prepolymerization solution, and irradiating to obtain the injectable antibacterial composite hydrogel after uniform ultrasonic dispersion.
In the first step, the water-soluble monomer includes one or more of water-soluble monomers containing a nitrogen atom.
Preferably, the water-soluble monomer in the first step includes one or more of N-isopropylacrylamide, methacrylamide, N- [ tris (hydroxymethyl) methyl ] acrylamide, N-vinylcyclohexamide, N-acryloyl-N-alkylpiperazine, diethylacrylamide, isopropylacrylamide acrylate, N-hydroxymethylpropylacrylamide, vinylmethyloxazolidinone, and N-vinylcaprolactam.
In the first step, the initiator comprises any one of benzophenone, ammonium persulfate and potassium persulfate.
In the first step, the mass ratio of the water-soluble monomer to the initiator is (0.1-1): 100.
in the second step, the particle diameter of the attapulgite is 100-325 meshes, and the concentration of the attapulgite is 0.1-10wt%.
In the second step, the siloxane precursor comprises one or more than two of siloxane precursors containing sulfydryl and/or free amino, and the concentration of the siloxane precursor is 1-10wt%.
The siloxane precursor containing sulfydryl comprises propyl trimethoxy silane, mercaptopropyl triethoxy silane, bis- [3- (triethoxy silicon) propyl ] -tetrasulfide or bis- [3- (triethoxy silicon) propyl ] -disulfide.
The siloxane precursor containing free amino comprises gamma-aminopropyltriethoxysilane, N- (beta-aminoethyl) -gamma-aminopropyltrimethoxysilane, N- (beta-aminoethyl) -gamma-aminopropyltriethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxysilane, 4-amino-3,3-dimethylbutyltrimethoxysilane or diethylenetriaminopropyltrimethoxysilane.
The acid catalyst comprises HCOOH, C 2 H 5 COOH、HCl、H 2 SO 4 、HNO 3 、H 3 PO and HBr.
The mass ratio of the acid catalyst to the siloxane precursor is 10 -6 ~0.1:1。
The silver source comprises any one or more than two of silver nitrate, silver trifluoromethanesulfonate and silver trifluoromethyl acetate.
The mass ratio of the silver source to the modified attapulgite is (0.1-1): 1.
the illumination includes one of ultraviolet illumination or visible light illumination.
An injectable antibacterial composite hydrogel crosslinked by silver-carrying attapulgite has injectable and spreadable properties, and can be applied to antibacterial agents and wound dressings.
The design idea of the invention is as follows: the attapulgite is an aluminosilicate mineral which has a rod-shaped crystal structure, contains water and is rich in magnesium, has a rod crystal length of about 1 to 5um and a diameter of 20-70 nanometers, and is a natural one-dimensional nano material. The surface of the attapulgite shows negative electricity because of containing a large amount of hydroxyl, which is very favorable for modifying and loading the metal nano material. Therefore, firstly, the surface of the attapulgite is modified with sulfhydryl functional groups, and a large amount of hydroxyl and sulfhydryl functional groups on the surface of the attapulgite can greatly increase the silver carrying capacity; and then dispersing the nano silver into a hydrophilic polymer with a branched chain containing nitrogen atoms, forming nano silver after ultraviolet irradiation, taking the nano silver loaded attapulgite material as a multi-site cross-linking agent, and forming a stable hydrogel material by the dynamic coordination action of the nano silver on the surface and the nitrogen atoms in the hydrophilic polymer. The introduction of the attapulgite loaded with the nano silver can improve the mechanical property of the hydrogel material on the one hand, and on the other hand, a large number of functional groups (such as hydroxyl, sulfydryl and the like) on the surface of the attapulgite and nitrogen-containing functional groups on the surface of the hydrophilic polymer have synergistic action, so that the nano silver can be effectively dispersed and stabilized, the aggregation inactivation and 'burst release' of the nano silver groups can be avoided, the antibacterial property of the hydrogel material can be fully improved and prolonged, and the injectable antibacterial composite hydrogel has wide application prospects in the fields of wound healing and the like.
The invention has the following beneficial effects:
1. the attapulgite serving as a natural one-dimensional nano material is introduced into a hydrogel system, so that the mechanical properties (such as toughness and the like) of the hydrogel can be effectively improved.
2. The synergistic effect of a large amount of functional groups such as hydroxyl, sulfydryl and the like on the surface of the attapulgite and the nitrogen-containing functional groups on the surface of the hydrophilic polymer can effectively improve the load capacity of the nano silver, simultaneously efficiently disperse and stabilize the nano silver, avoid the aggregation inactivation and 'burst release' of the nano silver groups, and fully improve and prolong the antibacterial performance of the hydrogel material.
3. The preparation of the nano silver adopts a light reduction method, avoids using a large amount of toxic reducing agents and dispersing agents, has mild reaction conditions, and is green and environment-friendly.
4. The preparation process of the injectable antibacterial composite hydrogel crosslinked by the silver-loaded attapulgite is simple, the period is short, harsh reaction conditions are not needed, and the large-scale production is facilitated.
Drawings
FIG. 1 is a photograph of a hydrogel sample in example 1 of the present invention.
Fig. 2 is a TEM image of silver nanoparticles in example 1 of the present invention.
Fig. 3 is an ultraviolet-visible absorption spectrum of silver nanoparticles in example 1 of the present invention.
FIG. 4 is a tensile stress strain curve for the hydrogels of inventive example 1 and comparative example 1.
Fig. 5 is a release curve of elemental silver in example 1 of the present invention and comparative example 1.
FIG. 6 shows Escherichia coli (E. coli) The photographs were attached to the hydrogels of comparative example 1 (a), comparative example 2 (b) and inventive example 1 (c).
Detailed Description
A preparation method of injectable antibacterial composite hydrogel crosslinked by silver-loaded attapulgite comprises the following steps:
firstly, mixing a water-soluble monomer and an initiator, and initiating polymerization under the stirring condition to obtain a pre-polymerization solution;
secondly, ultrasonically dispersing the attapulgite in a water solution containing an organosilane precursor, adding an acid catalyst under the stirring condition, filtering and washing to remove the redundant organosilane precursor after the reaction is finished, ultrasonically dispersing the filtered precipitate in a deionized water solution containing a silver source, and filtering and washing after adsorption saturation to obtain the attapulgite material loaded with silver ions;
and thirdly, adding the attapulgite loaded with silver ions into the prepolymerization solution, and irradiating to obtain the injectable antibacterial composite hydrogel after uniform ultrasonic dispersion.
Example 1
(1) Dissolving 10g N-isopropylacrylamide (NIPAM) and 0.1g Ammonium Persulfate (APS) in 90mL of deionized water, introducing nitrogen for 30min to remove oxygen in the system, and heating to initiate polymerization to obtain a pre-polymerization solution.
(2) Adding 5g of attapulgite and 5g of mercaptopropyltriethoxysilane into 90mL of deionized water, ultrasonically dispersing for 3h, adding one drop (about 0.05 mL) of acetic acid solution with the concentration of 0.01M, continuously stirring for 1h, filtering, washing the precipitate with water and ethanol for three times, and drying; ultrasonically dispersing the prepared modified attapulgite into 100mL of deionized water, slowly adding 0.5g of silver nitrate, continuously stirring for 2h, filtering, washing the precipitate with the deionized water for three times, and drying to obtain the silver ion-loaded attapulgite.
(3) And (2) adding 1g of attapulgite loaded with silver ions into the pre-polymerization solution obtained in the step (1), and irradiating by ultraviolet light for 30min to obtain the injectable antibacterial composite hydrogel.
Example 2
(1) 5g of methacrylamide and 0.05g Ammonium Persulfate (APS) are dissolved in 95mL of deionized water, nitrogen is introduced for 30min to remove oxygen in the system, and polymerization is initiated by heating to obtain a pre-polymerization solution.
(2) Adding 1g of attapulgite and 10g of gamma-aminopropyltriethoxysilane into 89mL of deionized water, ultrasonically dispersing for 3h, adding one drop (about 0.05 mL) of formic acid solution with the concentration of 0.01M, continuously stirring for 1h, filtering, washing the precipitate with water and ethanol for three times, and drying; ultrasonically dispersing the prepared modified attapulgite into 100mL of deionized water, slowly adding 1g of silver triflate, continuously stirring for 2h, filtering, washing the precipitate with the deionized water for three times, and drying to obtain the attapulgite loaded with silver ions.
(3) And (2) adding 0.05g of attapulgite loaded with silver ions into the pre-polymerization solution obtained in the step (1), and irradiating by ultraviolet light for 30min to obtain the injectable antibacterial composite hydrogel.
Example 3
(1) Dissolving 10 g-hydroxymethyl propyl acrylamide and 0.01 g Ammonium Persulfate (APS) in 90mL of deionized water, introducing nitrogen for 30min to remove oxygen in the system, and heating to initiate polymerization to obtain a pre-polymerization solution.
(2) Adding 1g of attapulgite and 1g of mercaptopropyltriethoxysilane into 98mL of deionized water, ultrasonically dispersing for 3h, adding one drop (about 0.05 mL) of sulfuric acid solution with the concentration of 0.01M, continuously stirring for 1h, filtering, washing the precipitate with water and ethanol for three times, and drying; ultrasonically dispersing the prepared modified attapulgite into 100mL of deionized water, slowly adding 0.1g of silver nitrate, continuously stirring for 2h, filtering, washing the precipitate with deionized water for three times, and drying to obtain the silver ion loaded attapulgite.
(3) And (2) adding 0.5g of attapulgite loaded with silver ions into the pre-polymerization solution obtained in the step (1), and irradiating by ultraviolet light for 30min to obtain the injectable antibacterial composite hydrogel.
Comparative example 1
Dissolving 10g of N-isopropylacrylamide (NIPAM), 0.1g Ammonium Persulfate (APS) and 0.1g of N, N-Methylene Bisacrylamide (MBA) in 90mL of deionized water, introducing nitrogen for 30min to remove oxygen in the system, heating to initiate polymerization to obtain hydrogel crosslinked by covalent bonds, placing the hydrogel in 0.1 g/mL of silver nitrate solution, taking out after adsorption saturation, wiping off water on the surface by using filter paper, and irradiating by ultraviolet light for 30min to obtain the covalently crosslinked nano-silver-containing hydrogel material.
Comparative example 2
(1) Dissolving 10g N-isopropylacrylamide (NIPAM) and 0.1g Ammonium Persulfate (APS) in 90mL of deionized water, introducing nitrogen for 30min to remove oxygen in the system, and heating to initiate polymerization to obtain a pre-polymerization solution.
(2) Adding 5g attapulgite and 5g mercaptopropyltriethoxysilane into 90mL deionized water, ultrasonically dispersing for 3h, adding one drop (about 0.05 mL) of 0.01M acetic acid solution, stirring for 1h, filtering, washing precipitate with water and ethanol for three times, and drying
(3) And (2) adding 1g of modified attapulgite into the premixed liquid in the step (1), and irradiating by ultraviolet light for 30min to obtain the injectable antibacterial composite hydrogel.
The samples prepared by the inventive examples and the comparative samples were compared for relevant properties:
(1) Hydrogel samples prepared by the plate method were cut into small Bao Changtiao (size 5.0 cm × 1.0 cm × 0.13 cm). The pull-up rate was set to 20 mm/min. The tensile strain at break and the tensile stress at break are the stress and strain, respectively, occurring at the point of break.
From FIG. 4, it can be seen that the BIS crosslinked PHEMA hydrogel (comparative example 1) fractured at a stress of 0.42 MPa with a strain of only 30%, whereas the hydrogel in example 1 had a stress of only 0.24 MPa at fracture but had a strain of about 120% which is 4 times that of the hydrogel in comparative example 1, which indicates that the nanosilver-loaded attapulgite material effectively improved the toughness of the hydrogel.
(2) The hydrogel samples were made into cylinders of 12 mm diameter and height 15 mm and placed in the center of the test station and then compressed from top to bottom with a load compression rate of 1.0 mm/min. When the strain of the compression test reaches 80%, the compression test process ends.
The compression test of the hydrogel showed that the hydrogel in comparative example 1 was damaged at a strain of 47%, the stress at failure was 1.5 MPa, and the hydrogel loaded with nanosilver (example 1) was not damaged even when the strain reached 80%. The stress of the hydrogel reaches 2.5 Mpa when the hydrogel is compressed to 80 percent, and the stress of the hydrogel still reaches 1.6 Mpa after the hydrogel is compressed for the second time. These results show that the introduction of the attapulgite loaded with nano-silver significantly improves the mechanical properties of the hydrogel.
(3) The release of silver from the hydrogel was performed in saline and dried hydrogel pieces (1.0 + -0.2 mm in diameter, 0.2 + -0.05 mm in thickness, 10 + -2 mg in mass) were placed in sample vials containing 10 mL saline. The sample vial was shaken in a water bath shaker and the temperature was controlled at 25 ℃. After 1, 3, 5, 15, 28 days, two milliliters of solution was removed from the sample and fresh 2.0 mL saline was added. 1.5 mL concentrated nitric acid is added into the taken solution, and after digestion for 4 hours at 80 ℃, the solution is cooled to be fixed to 10 mL, and then the concentration of silver in a sample is measured.
The release kinetics of silver in the hydrogel is researched, and the content of silver in the solution is measured by controlling time sampling, so that the relation between the cumulative release amount of Ag in the hydrogel and the time can be obtained. It can be seen from fig. 5 that the cumulative release amount gradually increases with time, and does not show a linear increase but a tendency to increase sharply and then decrease. The hydrogel system in comparative example 1 released silver ions at a concentration of up to 3.8mg/g after 28 days, whereas the silver ion released concentration in example 1 was only 0.7mg/g. The results show that the introduction of the attapulgite loaded with the nano silver obviously improves the slow release performance of silver ions, thereby prolonging the action aging of the silver ions.
(4) In order to further research the antibacterial capability of the hydrogel, the adhesion condition of escherichia coli on the surface of the hydrogel is researched, the escherichia coli is adhered on the surface of the hydrogel in large quantity in a comparative example 1 (figure 6 a), after nano-silver is introduced into the system, the adhesion quantity of the escherichia coli on the surface of the hydrogel in the comparative example 1 (figure 6 b) is obviously reduced due to the excellent antibacterial performance of the nano-silver, the attapulgite carrying the nano-silver is introduced into the hydrogel system, the loading quantity of the nano-silver is further improved, and meanwhile, due to the slow release effect, the hydrogel system can effectively avoid the 'burst release' of the nano-silver, and the higher concentration of the nano-silver is maintained, so that the optimal antibacterial performance is shown (figure 6 c).
Claims (7)
1. A preparation method of injectable antibacterial composite hydrogel crosslinked by silver-loaded attapulgite is characterized by comprising the following steps: the composite hydrogel comprises 5-20wt% of base material and 80-95wt% of deionized water, wherein the base material comprises 1-10wt% of nano-silver loaded concave-convex rod material and 90-99wt% of hydrophilic polymer; the preparation method comprises the following steps:
firstly, mixing a water-soluble monomer and an initiator, and initiating polymerization under the stirring condition to obtain a pre-polymerization solution;
secondly, ultrasonically dispersing the attapulgite in a siloxane-containing precursor aqueous solution, adding an acid catalyst under the stirring condition, after the reaction is finished, filtering and washing to remove redundant siloxane precursors to obtain modified attapulgite, ultrasonically dispersing the filtered modified attapulgite in a deionized water solution containing a silver source, adsorbing and saturating, filtering, and washing to obtain the attapulgite material loaded with silver ions;
thirdly, adding the attapulgite loaded with silver ions into the prepolymerization solution, and after uniform ultrasonic dispersion, illuminating to obtain injectable antibacterial composite hydrogel;
wherein the water-soluble monomer in the first step comprises one or more of N-isopropylacrylamide, methacrylamide, N- [ tris (hydroxymethyl) methyl ] acrylamide, N-vinylcyclohexamide, N-acryloyl-N-alkylpiperazine, diethylacrylamide, isopropylacrylamide acrylate, N-hydroxymethylpropylacrylamide, vinylmethyloxazolidinone, and N-vinylcaprolactam;
in the second step, the siloxane precursor comprises one or more than two of siloxane precursors containing sulfydryl and/or free amino;
the silver source comprises any one or more than two of silver nitrate, silver trifluoromethanesulfonate and silver trifluoromethylacetate;
the illumination is ultraviolet illumination.
2. The preparation method of the injectable antibacterial composite hydrogel crosslinked by the silver-loaded attapulgite according to claim 1, which is characterized in that: in the first step, the initiator comprises any one of benzophenone, ammonium persulfate and potassium persulfate; the mass ratio of the water-soluble monomer to the initiator is (0.1-1): 100.
3. the preparation method of the injectable antibacterial composite hydrogel crosslinked by the silver-loaded attapulgite according to claim 1, which is characterized in that: in the second step, the particle size of the attapulgite is 100-325 meshes, and the concentration of the attapulgite is 0.1-10wt%; the concentration of the siloxane precursor in the second step is 1-10wt%.
4. The preparation method of the injectable antibacterial composite hydrogel crosslinked by the silver-loaded attapulgite according to claim 1, which is characterized in that: the siloxane precursor containing sulfydryl comprises propyl trimethoxy silane, mercaptopropyl triethoxy silane, bis- [3- (triethoxy silicon) propyl ] -tetrasulfide or bis- [3- (triethoxy silicon) propyl ] -disulfide.
5. The preparation method of the injectable antibacterial composite hydrogel crosslinked by the silver-loaded attapulgite according to claim 1, which is characterized in that: the siloxane precursor containing free amino comprises gamma-aminopropyltriethoxysilane, N- (beta-aminoethyl) -gamma-aminopropyltrimethoxysilane, N- (beta-aminoethyl) -gamma-aminopropyltriethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxysilane, 4-amino-3,3-dimethylbutyltrimethoxysilane or diethylenetriaminopropyltrimethoxysilane.
6. The preparation method of the injectable antibacterial composite hydrogel crosslinked by the silver-loaded attapulgite according to claim 1, which is characterized in that: the acid catalyst comprises HCOOH, C 2 H 5 COOH、HCl、H 2 SO 4 、HNO 3 、H 3 Any one or more of PO and HBr; the mass ratio of the acid catalyst to the siloxane precursor is 10 -6 -0.1: 1; the mass ratio of the silver source to the modified attapulgite is (0.1-1): 1.
7. the application of the composite hydrogel prepared by the preparation method of the injectable antibacterial composite hydrogel crosslinked by the silver-loaded attapulgite in the preparation of antibacterial agents and wound dressings is characterized in that: the composite hydrogel has injectable and spreadable properties.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011280301.6A CN112315976B (en) | 2020-11-16 | 2020-11-16 | Injectable antibacterial composite hydrogel crosslinked by silver-loaded attapulgite, and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011280301.6A CN112315976B (en) | 2020-11-16 | 2020-11-16 | Injectable antibacterial composite hydrogel crosslinked by silver-loaded attapulgite, and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112315976A CN112315976A (en) | 2021-02-05 |
CN112315976B true CN112315976B (en) | 2022-10-11 |
Family
ID=74318751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011280301.6A Active CN112315976B (en) | 2020-11-16 | 2020-11-16 | Injectable antibacterial composite hydrogel crosslinked by silver-loaded attapulgite, and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112315976B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113444262B (en) * | 2021-06-07 | 2022-09-09 | 中山大学 | Temperature response hydrogel and preparation method and application thereof |
CN115819775B (en) * | 2023-02-22 | 2023-06-16 | 山东东岳有机硅材料股份有限公司 | Antibacterial self-repairing polysiloxane elastomer and preparation method thereof |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11140137A (en) * | 1997-11-04 | 1999-05-25 | Nippon Chem Ind Co Ltd | Antibacterial temperature-sensitive water-absorbing resin and its production |
WO2002018699A1 (en) * | 2000-09-01 | 2002-03-07 | Shanghai Lange Scientific Technology Co., Ltd. | A nanometre-silver, long-acting, broad spectrum, antimicrobial, mouldproof granule and its producing methods |
CN1339257A (en) * | 2000-08-28 | 2002-03-13 | 北京市建筑材料科学研究院 | Palygorskite type inorganic anti-biotic agent and its preparing method |
CN1345537A (en) * | 2000-09-27 | 2002-04-24 | 北京市建筑材料科学研究院 | Silver carried complex ion palygorskite type inorganic germicide |
CN1568703A (en) * | 2003-07-24 | 2005-01-26 | 合肥工业大学 | Attapulgite-argentum nanometer composite antibiotic material and preparation method thereof |
CN101300981A (en) * | 2008-05-15 | 2008-11-12 | 兰州大学 | Nano silver-carrying concave-convex stick anti-bacteria agent and preparation thereof |
CN101812157A (en) * | 2010-03-31 | 2010-08-25 | 淮阴师范学院 | Synthesis method of polymeric (N-isopropyl acrylamide)/attapulgite composite hydrogel |
CN102850477A (en) * | 2012-08-31 | 2013-01-02 | 北京理工大学 | Clay-based nano-silver composite hydrogel and preparation method thereof |
CN103126977A (en) * | 2013-03-06 | 2013-06-05 | 武汉华纳联合药业有限公司 | Intelligent nano-silver hydrogel |
CN103357888A (en) * | 2013-07-05 | 2013-10-23 | 淮阴工学院 | Green synthetic method of one-dimensional core-shell type nano silver/attapulgite clay composite material |
CN107051341A (en) * | 2017-04-25 | 2017-08-18 | 淮阴师范学院 | Preparation method with optics temperature-sensitive composite hydrogel |
CN107096915A (en) * | 2017-04-20 | 2017-08-29 | 淮阴工学院 | The preparation method of attapulgite/bar-shaped silver powder of galactic nucleus shell structure |
WO2017223261A2 (en) * | 2016-06-23 | 2017-12-28 | 3M Innovative Properties Company | Hydrogels, articles comprising hydrogels, and methods thereof |
CN107522875A (en) * | 2016-06-20 | 2017-12-29 | 中国科学院宁波材料技术与工程研究所 | Hydrogel, its preparation method and the application of Nano silver grain crosslinking |
CN110302146A (en) * | 2019-08-19 | 2019-10-08 | 中国科学院兰州化学物理研究所 | A kind of preparation and application of injectable attapulgite composite supramolecular hydrogel |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050266081A1 (en) * | 2004-05-26 | 2005-12-01 | Rogozinski Wallace J | Antimicrobial silver hydrogels |
-
2020
- 2020-11-16 CN CN202011280301.6A patent/CN112315976B/en active Active
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11140137A (en) * | 1997-11-04 | 1999-05-25 | Nippon Chem Ind Co Ltd | Antibacterial temperature-sensitive water-absorbing resin and its production |
CN1339257A (en) * | 2000-08-28 | 2002-03-13 | 北京市建筑材料科学研究院 | Palygorskite type inorganic anti-biotic agent and its preparing method |
WO2002018699A1 (en) * | 2000-09-01 | 2002-03-07 | Shanghai Lange Scientific Technology Co., Ltd. | A nanometre-silver, long-acting, broad spectrum, antimicrobial, mouldproof granule and its producing methods |
CN1345537A (en) * | 2000-09-27 | 2002-04-24 | 北京市建筑材料科学研究院 | Silver carried complex ion palygorskite type inorganic germicide |
CN1568703A (en) * | 2003-07-24 | 2005-01-26 | 合肥工业大学 | Attapulgite-argentum nanometer composite antibiotic material and preparation method thereof |
CN101300981A (en) * | 2008-05-15 | 2008-11-12 | 兰州大学 | Nano silver-carrying concave-convex stick anti-bacteria agent and preparation thereof |
CN101812157A (en) * | 2010-03-31 | 2010-08-25 | 淮阴师范学院 | Synthesis method of polymeric (N-isopropyl acrylamide)/attapulgite composite hydrogel |
CN102850477A (en) * | 2012-08-31 | 2013-01-02 | 北京理工大学 | Clay-based nano-silver composite hydrogel and preparation method thereof |
CN103126977A (en) * | 2013-03-06 | 2013-06-05 | 武汉华纳联合药业有限公司 | Intelligent nano-silver hydrogel |
CN103357888A (en) * | 2013-07-05 | 2013-10-23 | 淮阴工学院 | Green synthetic method of one-dimensional core-shell type nano silver/attapulgite clay composite material |
CN107522875A (en) * | 2016-06-20 | 2017-12-29 | 中国科学院宁波材料技术与工程研究所 | Hydrogel, its preparation method and the application of Nano silver grain crosslinking |
WO2017223261A2 (en) * | 2016-06-23 | 2017-12-28 | 3M Innovative Properties Company | Hydrogels, articles comprising hydrogels, and methods thereof |
CN107096915A (en) * | 2017-04-20 | 2017-08-29 | 淮阴工学院 | The preparation method of attapulgite/bar-shaped silver powder of galactic nucleus shell structure |
CN107051341A (en) * | 2017-04-25 | 2017-08-18 | 淮阴师范学院 | Preparation method with optics temperature-sensitive composite hydrogel |
CN110302146A (en) * | 2019-08-19 | 2019-10-08 | 中国科学院兰州化学物理研究所 | A kind of preparation and application of injectable attapulgite composite supramolecular hydrogel |
Non-Patent Citations (5)
Title |
---|
Antibacterial Acrylamide Hydrogels Containing Silver Nanoparticles by Simultaneous Photoinduced Free Radical Polymerization and Electron Transfer Processes;Mustafa Uygun et al;《Macromolecular Chemistry and Physics》;20091103;全文 * |
Synthesis and characterization of temperature-sensitive hydrogels;Xiangming Hu et al;《e-Polymers》;20150831;第15卷(第5期);全文 * |
凹凸棒石-银纳米复合抗菌材料制备方法和表征;陈天虎等;《硅酸盐通报》;20050428(第02期);全文 * |
海藻酸钠-聚丙烯酰胺/凹凸棒土复合水凝胶的吸附性能研究;彭勇刚等;《印染助剂》;20180220(第02期);全文 * |
纳米载银凹凸棒的制备和表征及其抗菌性能;王临艳等;《国际检验医学杂志》;20110530(第07期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN112315976A (en) | 2021-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112315976B (en) | Injectable antibacterial composite hydrogel crosslinked by silver-loaded attapulgite, and preparation method and application thereof | |
CN110067042B (en) | Konjac glucomannan-based antibacterial hydrogel fiber and preparation method thereof | |
Chen et al. | Mussel-inspired ultra-stretchable, universally sticky, and highly conductive nanocomposite hydrogels | |
CN102321255A (en) | Ion type nano-composite hydrogel and preparation method thereof | |
CN108276593B (en) | Preparation method of self-repairing nano composite hydrogel integrating induction of ultraviolet-visible-near infrared light | |
CN102206351B (en) | Sericin-based semi-interpenetrating temperature-sensitive nano-composite hydro-gel and preparation method thereof | |
CN111494702B (en) | Antibacterial hydrogel and preparation method and application thereof | |
CN109942839B (en) | In-situ free radical polymerization gel with antibacterial and self-adhesive properties, and preparation method and application thereof | |
CN113637183A (en) | Modified graphene-loaded nano-silver/polyvinyl alcohol antibacterial hydrogel and preparation method thereof | |
CN111171361A (en) | Bacterial cellulose composite membrane for medical dressing and preparation method thereof | |
CN102373618B (en) | Silver-carried alginic acid fiber and preparation method thereof | |
CN109836596A (en) | The high-intensitive preparation method with the amylopectin composite hydrogel of high adherency of strong hydrogen bonding effect | |
CN112089685B (en) | Preparation method of temperature response type bacterial cellulose antibacterial nanogel | |
CN107522875B (en) | Silver nanoparticle crosslinked hydrogel, and preparation method and application thereof | |
CN110229383B (en) | Magnetic aerogel based on bisamidoxime cellulose/sodium alginate and preparation and application thereof | |
CN112402688A (en) | Biocompatible and antibacterial rapid hemostatic nano material and preparation method thereof | |
CN114045577A (en) | Silver-containing hydrogel type alginate fiber and preparation method thereof | |
Chen et al. | Removal of methylene blue dye from aqueous solutions by pullulan polysaccharide/polyacrylamide/activated carbon complex hydrogel adsorption | |
CN113861447B (en) | Modified hydroxypropyl chitosan adhesion self-healing hydrogel and preparation method and application thereof | |
CN111228302A (en) | Antibacterial hydrogel and preparation method and application thereof | |
CN111995799B (en) | Preparation method of nano-silver/cellulose composite antibacterial material | |
CN109897196A (en) | A kind of nano-chitosan-titanium dioxide-polyacrylamide composite catalyzing hydrogel and its preparation method and application | |
CN111647110B (en) | High-strength anti-swelling chitosan-based physical hydrogel and preparation method thereof | |
CN109675096A (en) | A kind of preparation method of chitin fiber aerogel dressing | |
CN115228443A (en) | Preparation and application of cellulose nanocrystalline reinforced composite gel for heavy metal ion adsorption |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |